IRA

Perhimpunan Reumatologi Indonesia
Indonesian Rheumatology Association
IRA Position Statement Tocilizumab for Covid-19

IRA Position Statement Tocilizumab for Covid-19

Responding to requests for information on the use of tocilizumab (TCZ) in patients with the 2019 corona virus disease (COVID-19), the Indonesian Rheumatology Association (IRA), which has been using TCZ as part of therapy in autoimmune rheumatism, intends to convey information about the drug and the precautions that need to be considered in its use.